(19)
(11) EP 3 071 192 A1

(12)

(43) Date of publication:
28.09.2016 Bulletin 2016/39

(21) Application number: 14815145.9

(22) Date of filing: 20.11.2014
(51) International Patent Classification (IPC): 
A61K 31/05(2006.01)
A61K 45/06(2006.01)
A61K 31/12(2006.01)
A61P 35/00(2006.01)
(86) International application number:
PCT/US2014/066543
(87) International publication number:
WO 2015/077411 (28.05.2015 Gazette 2015/21)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME

(30) Priority: 20.11.2013 US 201361906817 P

(71) Applicant: bioMmune Technologies Inc.
Vancouver, BC V6C 3A6 (CA)

(72) Inventors:
  • JEFFERIES, Wilfred A,
    Vancouver, British Columbia V6m 1E3 (CA)
  • GABATHULER, Reinhard
    Montreal, Québec H3E 1Z4 (CA)
  • ANDERSEN, Raymond
    Vancouver, British Columbia V6T 1Z3 (CA)
  • WILLIAMS, David
    Vancouver, British Columbia V6T 1Z3 (CA)
  • NOHARA, Lilian
    Chilliwack, British Columbia V2R 5Z7 (CA)

(74) Representative: Cooley (UK) LLP 
Dashwood 69 Old Broad Street
London EC2M 1QS
London EC2M 1QS (GB)

   


(54) CURCUPHENOL COMPOUNDS FOR INCREASING MHC-I EXPRESSION